Page last updated: 2024-10-30

losartan and Adhesions, Tissue

losartan has been researched along with Adhesions, Tissue in 2 studies

Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position

Research Excerpts

ExcerptRelevanceReference
"Transforming growth factor beta 1 is a key molecule in the development of postoperative fibrosis."2.58Potential Usefulness of Losartan as an Antifibrotic Agent and Adjunct to Platelet-Rich Plasma Therapy to Improve Muscle Healing and Cartilage Repair and Prevent Adhesion Formation. ( Bolia, I; Briggs, K; Huard, J; Lowe, WR; Philippon, MJ; Utsunomiya, H, 2018)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Huard, J1
Bolia, I1
Briggs, K1
Utsunomiya, H1
Lowe, WR1
Philippon, MJ1
Dinarvand, P1
Farhadian, S1
Seyedjafari, E1
Shafiee, A1
Jalali, A1
Sanaei-Rad, P1
Dinarvand, B1
Soleimani, M1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
A Pilot Study of Losartan to Reduce Radiation Induced Fibrosis in Breast Cancer Patients[NCT05637216]Phase 240 participants (Anticipated)Interventional2023-08-17Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

1 review available for losartan and Adhesions, Tissue

ArticleYear
Potential Usefulness of Losartan as an Antifibrotic Agent and Adjunct to Platelet-Rich Plasma Therapy to Improve Muscle Healing and Cartilage Repair and Prevent Adhesion Formation.
    Orthopedics, 2018, Sep-01, Volume: 41, Issue:5

    Topics: Animals; Antifibrinolytic Agents; Cartilage; Disease Models, Animal; Fibrosis; Humans; Losartan; Mus

2018

Other Studies

1 other study available for losartan and Adhesions, Tissue

ArticleYear
Novel approach to reduce postsurgical adhesions to a minimum: administration of losartan plus atorvastatin intraperitoneally.
    The Journal of surgical research, 2013, May-01, Volume: 181, Issue:1

    Topics: Angiotensin Receptor Antagonists; Animals; Atorvastatin; Heptanoic Acids; Hydroxymethylglutaryl-CoA

2013